Manipulating gene expression in neurons with CRISPR

CRISPR activation enables flexible upregulation of selected genes in cultured neurons and the adult nervous system. Here, neurons in the rat nucleus accumbens (a key brain reward structure) were targeted for CRISPR-based gene activation. Fluorescent reporter molecules mark the protein product of a gene targeted for activation (green), neurons expressing a CRISPR guide RNA (red), and DNA (blue).
Credit: Katherine Savell & Nancy Carullo, Day Lab, University of Alabama at Birmingham

Neuroscientists have used CRISPR/Cas9 genome editing technology to regulate genes in the rat brain. Described in eNeuro, this technique paves the way for researchers to probe genetic influences on brain health and disease in model organisms that more closely resemble human conditions.

Studying genes in the brain is expensive and time-consuming, often relying on transgenic animals, such as fruit flies and mice, designed to assess one gene at a time. Despite rapid advances in the development of powerfully precise CRISPR/Cas9 systems, adapting these for use in the central nervous system has proved challenging.

A neuron-optimized CRISPR activation system developed by Jeremy Day and colleagues overcomes these challenges.

The researchers demonstrate both in diverse cultured cells and in multiple regions of the live rat brain that their molecular tool is capable of quickly and efficiently increasing expression of targeted genes involved in learning and memory, plasticity, and neuronal development.

- Advertisement -


Story Source:

Materials provided by Society for Neuroscience. Note: Content may be edited for style and length.

Journal Reference:

  1. Katherine E. Savell, Svitlana V. Bach, Morgan E. Zipperly, Jasmin S. Revanna, Nicholas A. Goska, Jennifer J. Tuscher, Corey G. Duke, Faraz A. Sultan, Julia N. Burke, Derek Williams, Lara Ianov, Jeremy J. Day. A neuron-optimized CRISPR/dCas9 activation system for robust and specific gene regulation. eneuro, 2019; ENEURO.0495-18.2019 DOI: 10.1523/ENEURO.0495-18.2019

Disclaimer: is not responsible for the accuracy of news releases posted by contributing institutions or for the use of any information accessed through the website.

- Advertisement -